David A. Schwartz, MD, MPH, has been appointed chairman of the Department of Medicine at the University of Colorado School of Medicine. His appointment was effective Jan. 1, 2011.
A Professor of Medicine and Immunology, Dr. Schwartz's research has focused on the genetics and epigenetics of environmental lung disease. He has determined that a variant of the gene TLR4 predisposes some individuals to be more susceptible to adverse effects of bacteria, and has also demonstrated that a variant in a mucus encoding gene in the lung markedly enhances the risk of pulmonary fibrosis.
Dr. Schwartz earned his undergraduate degree at the University of Rochester and his MD from the University of California, San Diego School of Medicine. He was an intern, resident and chief resident at Boston City Hospital before earning his MPH at the Harvard School of Public Health. He subsequently completed a fellowship with the Division of Pulmonary and Critical Care Medicine at the University of Washington.
In 1988, Dr. Schwartz joined the Department of Internal Medicine at the University of Iowa, where he became a full professor and was director of the Center for Environmental Lung Disease. He joined Duke University Medical Center in 2000. During his tenure at Duke, he served as a Professor of Medicine, Genetics, and Environmental Sciences; Chief of the Division of Pulmonary and Critical Care Medicine; and Director of the Center for Environmental Genomics. He became director of the National Institute of Environmental Health Sciences (NIEHS), a part of the National Institutes of Health (NIH), in 2005. He joined National Jewish Health as a Professor of Medicine, Pediatrics, and Immunology, and Director of the Center for Genes, Environment, and Health in 2008.
Among other awards, Dr. Schwartz received the American Thoracic Society Lifetime …